TECH · BIO-TECHNE Corp

$71.60 -0.17 (-0.24%) At close · Jul 24

Market Cap

$11.21B

156.57M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed	Seller	Relationship	Shares	Market Value	Approx. Sale	Broker
2026-05-08	JOSHUA MOLHO	Director	6,636	$320,417	2026-05-08	Morgan Stanley Smith Barney LLC Executive Financial Services
2026-02-17	JOSHUA MOLHO	Director	1,976	$116,791	2026-02-17	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-08-25	ROBERT V. BAUMGARTNER4731 BONITA BAY BOULEVARD	Director	17,040	$957,849	2025-08-25	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-08-25	ROELAND NUSSE	Director	17,040	$960,388	2025-08-25	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-06-09	JOSHUA MOLHO	Officer	1,280	$63,705	2025-06-09	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-02-14	JOSHUA MOLHO	Domestic Partner of Director	1,860	$122,691	2025-02-14	Morgan Stanley Smith Barney LLC Executive Financial Services
2025-01-27	KIM KELDERMAN	Director, Officer	13,392	$1,031,854	2025-01-27	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-08-08	ROBERT V. BAUMGARTNER	Director	16,000	$1,153,664	2024-08-08	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-05-14	JOHN L HIGGINS	Director	4,000	$335,377	2024-05-14	Morgan Stanley Smith Barney LLC Executive Financial Services
2024-03-07	Nusse Roeland	Director	10,400	$800,626	2024-03-07	Charles Schwab Corp.
2023-08-30	ROELAND NUSSE	Director	8,939	$717,959	2023-08-30	Morgan Stanley Smith Barney LLC Executive Financial Services
2023-07-21	Kummeth Charles R.	Officer	80,000	$7,069,024	2023-07-21	UBS Financial Services, Inc.
2023-06-06	Charles Kummeth	Officer	50,000	$4,150,000	2023-06-06	UBS Financial Services Inc

Showing 1–13 of 13 filings

Key facts CIK 842023 CUSIP 09073M104 13F (30d) 118 filings 118 filers Visit website Investor relations